everolimus
Showing 1 - 25 of 387
Epilepsy Trial in Shenyang (Everolimus, Placebo)
Recruiting
- Epilepsy
- Everolimus
- Placebo
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Nov 5, 2022
Renal Angiomyolipoma Trial (Everolimus)
Not yet recruiting
- Renal Angiomyolipoma
- Everolimus
- (no location specified)
Aug 15, 2022
Bladder Cancer, Metastatic Transitional Cell Carcinoma Trial in New York (Everolimus)
Completed
- Bladder Cancer
- Metastatic Transitional Cell Carcinoma
- Everolimus
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 16, 2021
Glioblastoma Multiforme, Glioma of Brain Trial in Chandler, Phoenix, Scottsdale (Ribociclib, Everolimus)
Active, not recruiting
- Glioblastoma Multiforme
- Glioma of Brain
- Ribociclib
- Everolimus
-
Chandler, Arizona
- +2 more
Mar 10, 2022
Breast Tumors, Endocrine Breast Diseases, Tumor Metastasis Trial in Baltimore (letrozole, lapatinib, everolimus)
Terminated
- Breast Neoplasms
- +2 more
- letrozole
- +2 more
-
Baltimore, MarylandUniversity of Maryland Marlene & Stewart Greenebaum Cancer Cente
Feb 9, 2022
Solid Organ Malignancies, Adenoidcystic Carcinoma, Neuroendocrine Tumors Trial in Atlanta (Lenalidomide, Everolimus)
Completed
- Solid Organ Malignancies
- +2 more
- Lenalidomide
- Everolimus
-
Atlanta, Georgia
- +1 more
Nov 19, 2021
Renal Cell Carcinoma Trial in Shanghai (Anlotinib HCl, everolimus)
Not yet recruiting
- Renal Cell Carcinoma
- Anlotinib hydrochloride
- everolimus
-
Shanghai, China270 Dongan Road, Fudan University Shanghai Cancer Center
Nov 5, 2021
Breast Cancer Trial in Birmingham (Letrozole, Everolimus, TRC105)
Active, not recruiting
- Breast Cancer
- Letrozole
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 24, 2022
Uterine Sarcoma Trial (Everolimus)
Available
- Uterine Sarcoma
- Everolimus
- (no location specified)
Jun 30, 2021
Differentiated Thyroid Cancer Trial in Philadelphia (Everolimus, Sorafenib)
Active, not recruiting
- Differentiated Thyroid Cancer
- Everolimus
- Sorafenib
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Oct 18, 2021
Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,
Terminated
- Low Grade Glioma
- +3 more
- Everolimus
- Temozolomide
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 3, 2021
Neuroendocrine Tumors Trial in Boston, New York, Houston (LEE011, everolimus)
Active, not recruiting
- Neuroendocrine Tumors
- LEE011
- everolimus
-
Boston, Massachusetts
- +4 more
Feb 22, 2022
Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)
Terminated
- Glioma
- +2 more
- Dasatinib
- Everolimus
-
Ann Arbor, MichiganUniversity of Michigan Cancer Center
Oct 12, 2021
Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in
Terminated
- Estrogen Receptor-positive Breast Cancer
- +7 more
- everolimus
- +5 more
-
Atlanta, Georgia
- +2 more
Mar 10, 2022
Epilepsy, Tuberous Sclerosis Complex, Focal Cortical Dysplasia Trial in New York (Everolimus)
Completed
- Epilepsy
- +2 more
- Everolimus
-
New York, New YorkNew York University Langone Medical Center
Aug 31, 2021
Metastatic Midgut Neuroendocrine Tumor, Unresectable Midgut Neuroendocrine Tumor Trial (procedure, drug, other)
Not yet recruiting
- Metastatic Midgut Neuroendocrine Tumor
- Unresectable Midgut Neuroendocrine Tumor
- Biospecimen Collection
- +5 more
- (no location specified)
Mar 16, 2023
Breast Cancer, Ovarian Cancer Trial in Sioux Falls (niraparib, everolimus)
Active, not recruiting
- Breast Cancer
- Ovarian Cancer
- niraparib
- everolimus
-
Sioux Falls, South DakotaAvera Cancer Institute
Aug 24, 2021
Renal Failure Trial in Columbus (Everolimus, Sirolimus)
Completed
- Renal Failure
- Everolimus
- Sirolimus
-
Columbus, OhioThe Ohio State University Wexner Medical Center
Nov 2, 2021
Thyroid Cancer Trial in Philadelphia (Lenvatinib, Everolimus)
Suspended
- Thyroid Cancer
- Lenvatinib
- Everolimus
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Oct 7, 2021
Kidney Transplant Infection Trial in São Paulo (Sirolimus, Everolimus, Mycophenolic acid)
Completed
- Kidney Transplant Infection
- Sirolimus
- +2 more
-
São Paulo, Sao Paulo, BrazilHospital do Rim
Aug 23, 2021
Breast Cancer Trial in Guangzhou (Everolimus, Letrozole, Fluorouracil)
Completed
- Breast Cancer
- Everolimus
- +4 more
-
Guangzhou, Guangdong, ChinaSun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University
Sep 22, 2021
Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +3 more
- Cabozantinib
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 17, 2022
Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston
Recruiting
- Advanced Carcinoid Tumor
- +4 more
- Everolimus
- Lenvatinib
-
Houston, TexasM D Anderson Cancer Center
Oct 19, 2021